KCNH2 Antibody (Center) Blocking Peptide

The synthetic peptide sequence used to generate the antibody was selected from the Center region of human KCNH2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

[KCNH2; KCNH2; ERG1; HERG; LQT2; SQT1; ERG-1; H-ERG; HERG1; Kv11.1; ERG; ERG1; HERG; ERG-1; Eag-related protein 1; Ether-a-go-go-related protein 1; H-ERG; hERG-1; hERG1]

[Potassium voltage-gated channel subfamily H member 2; Potassium voltage-gated channel subfamily H member 2; potassium voltage-gated channel subfamily H member 2; potassium voltage-gated channel subfamily H member 2; Eag homolog; Ether-a-go-go-related gene potassium channel 1; ERG-1; Eag-related protein 1; Ether-a-go-go-related protein 1; H-ERG; hERG-1; hERG1; Voltage-gated potassium channel subunit Kv11.1]